{"count":12,"docs":"https://aiswingx.com/docs","items":[{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/Revenues","change":0.0725976848809584,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Revenue","label_en":"Revenue","label_ko":"\ub9e4\ucd9c","period_type":"duration","xbrl_tag":"Revenues"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/Revenues","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-46","unit":"USD","value":106096000000.0,"xbrl_fact_id":"f-46"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-47","unit":"USD","value":98915000000.0,"xbrl_fact_id":"f-47"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Revenue of USD 106,096,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/Revenues","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-46"},{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/OperatingIncomeLoss","change":0.9752204955900882,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Operating income","label_en":"Operating income","label_ko":"\uc601\uc5c5\uc774\uc775","period_type":"duration","xbrl_tag":"OperatingIncomeLoss"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/OperatingIncomeLoss","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-70","unit":"USD","value":4703000000.0,"xbrl_fact_id":"f-70"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-71","unit":"USD","value":2381000000.0,"xbrl_fact_id":"f-71"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Operating income of USD 4,703,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/OperatingIncomeLoss","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-70"},{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/NetIncomeLoss","change":1.9177277179236043,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Net income","label_en":"Net income","label_ko":"\uc21c\uc774\uc775","period_type":"duration","xbrl_tag":"NetIncomeLoss"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/NetIncomeLoss","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-98","unit":"USD","value":2979000000.0,"xbrl_fact_id":"f-98"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-99","unit":"USD","value":1021000000.0,"xbrl_fact_id":"f-99"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Net income of USD 2,979,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/NetIncomeLoss","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-98"},{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/IncomeTaxExpenseBenefit","change":0.5488958990536278,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Income tax","label_en":"Income tax","label_ko":"\ubc95\uc778\uc138","period_type":"duration","xbrl_tag":"IncomeTaxExpenseBenefit"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/IncomeTaxExpenseBenefit","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-04-01","source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-86","unit":"USD","value":982000000.0,"xbrl_fact_id":"f-86"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-87","unit":"USD","value":634000000.0,"xbrl_fact_id":"f-87"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Income tax of USD 982,000,000 for the period from 2026-04-01 to 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/IncomeTaxExpenseBenefit","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-86"},{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/ShareBasedCompensation","change":0.6870229007633588,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Stock-based compensation","label_en":"Stock-based compensation","label_ko":"\uc8fc\uc2dd\ubcf4\uc0c1","period_type":"duration","xbrl_tag":"ShareBasedCompensation"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/ShareBasedCompensation","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-296","unit":"USD","value":442000000.0,"xbrl_fact_id":"f-296"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-297","unit":"USD","value":262000000.0,"xbrl_fact_id":"f-297"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Stock-based compensation of USD 442,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/ShareBasedCompensation","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-296"},{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/NetCashProvidedByUsedInOperatingActivities","change":0.6417170308383697,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Operating cash flow","label_en":"Operating cash flow","label_ko":"\uc601\uc5c5\ud65c\ub3d9 \ud604\uae08\ud750\ub984","period_type":"duration","xbrl_tag":"NetCashProvidedByUsedInOperatingActivities"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/NetCashProvidedByUsedInOperatingActivities","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-258","unit":"USD","value":10594000000.0,"xbrl_fact_id":"f-258"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-259","unit":"USD","value":6453000000.0,"xbrl_fact_id":"f-259"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Operating cash flow of USD 10,594,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/NetCashProvidedByUsedInOperatingActivities","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-258"},{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/PaymentsToAcquirePropertyPlantAndEquipment","change":0.14074074074074075,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Capex","label_en":"Capex","label_ko":"\uc124\ube44\ud22c\uc790","period_type":"duration","xbrl_tag":"PaymentsToAcquirePropertyPlantAndEquipment"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/PaymentsToAcquirePropertyPlantAndEquipment","license":"https://aiswingx.com/terms","observations":[{"instant":false,"period_end":"2026-06-30","period_start":"2026-01-01","source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-264","unit":"USD","value":1540000000.0,"xbrl_fact_id":"f-264"},{"comparative":true,"instant":false,"period_end":"2025-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-265","unit":"USD","value":1350000000.0,"xbrl_fact_id":"f-265"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Capex of USD 1,540,000,000 for the period from 2026-01-01 to 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/PaymentsToAcquirePropertyPlantAndEquipment","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-264"},{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/AccountsReceivableNetCurrent","change":0.013323612961612911,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Accounts receivable","label_en":"Accounts receivable","label_ko":"\ub9e4\ucd9c\ucc44\uad8c","period_type":"instant","xbrl_tag":"AccountsReceivableNetCurrent"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/AccountsReceivableNetCurrent","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-158","unit":"USD","value":40309000000.0,"xbrl_fact_id":"f-158"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-159","unit":"USD","value":39779000000.0,"xbrl_fact_id":"f-159"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Accounts receivable of USD 40,309,000,000 as of 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/AccountsReceivableNetCurrent","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-158"},{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/InventoryNet","change":-0.08438117011327029,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Inventory","label_en":"Inventory","label_ko":"\uc7ac\uace0","period_type":"instant","xbrl_tag":"InventoryNet"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/InventoryNet","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-160","unit":"USD","value":17622000000.0,"xbrl_fact_id":"f-160"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-161","unit":"USD","value":19246000000.0,"xbrl_fact_id":"f-161"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Inventory of USD 17,622,000,000 as of 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/InventoryNet","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-160"},{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/CashAndCashEquivalentsAtCarryingValue","change":0.3402342363657873,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Cash","label_en":"Cash","label_ko":"\ud604\uae08","period_type":"instant","xbrl_tag":"CashAndCashEquivalentsAtCarryingValue"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/CashAndCashEquivalentsAtCarryingValue","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-154","unit":"USD","value":11329000000.0,"xbrl_fact_id":"f-154"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-155","unit":"USD","value":8453000000.0,"xbrl_fact_id":"f-155"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Cash of USD 11,329,000,000 as of 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/CashAndCashEquivalentsAtCarryingValue","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-154"},{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/Assets","change":0.000907161845561612,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Total assets","label_en":"Total assets","label_ko":"\ucd1d\uc790\uc0b0","period_type":"instant","xbrl_tag":"Assets"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/Assets","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-178","unit":"USD","value":253768000000.0,"xbrl_fact_id":"f-178"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-179","unit":"USD","value":253538000000.0,"xbrl_fact_id":"f-179"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Total assets of USD 253,768,000,000 as of 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/Assets","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-178"},{"accession":"0000064803-26-000098","article_url":null,"attribution":"aiSwingX \u2014 https://aiswingx.com/n/0000064803-26-000098/StockholdersEquity","change":0.05966974233520355,"cik":64803,"company":"CVS HEALTH CORPORATION","concept":{"label":"Total equity","label_en":"Total equity","label_ko":"\uc790\uae30\uc790\ubcf8","period_type":"instant","xbrl_tag":"StockholdersEquity"},"filed_at":"2026-08-05","filing_index_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm","filing_url":"https://aiswingx.com/f/0000064803-26-000098","form":"10-Q","id":"0000064803-26-000098/StockholdersEquity","license":"https://aiswingx.com/terms","observations":[{"instant":true,"period_end":"2026-06-30","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-236","unit":"USD","value":79702000000.0,"xbrl_fact_id":"f-236"},{"comparative":true,"instant":true,"period_end":"2025-12-31","period_start":null,"source_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-237","unit":"USD","value":75214000000.0,"xbrl_fact_id":"f-237"}],"statement":"CVS HEALTH CORPORATION (CVS) reported Total equity of USD 79,702,000,000 as of 2026-06-30 in its 10-Q (accession 0000064803-26-000098, filed 2026-08-05).","ticker":"CVS","url":"https://aiswingx.com/n/0000064803-26-000098/StockholdersEquity","verify_url":"https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/cvs-20260630.htm#f-236"}],"limit":100,"note":"Inline XBRL facts as filed with the SEC, each with a permanent citation URL and a deep link to the figure in the filing document.","offset":0,"total":12}